A large-scale international study involving researchers from the Drug Safety Research Unit (DSRU), UK, highlights the relationship between SARS-CoV-2 infection, certain COVID-19 vaccines, and Guillain-Barré syndrome (GBS).
Osivax has announced that all participants have completed their final visit in the Phase 2a clinical booster trial (NCT06582277) evaluating OVX836, Osivax’ broad-spectrum influenza A vaccine candidate.
Just when pharmaceutical supply chains had begun to recover from the chaos of the pandemic, companies are now faced with the threat of US tariffs and the ongoing investigation into the United States’ reliance on drug imports.
Brenntag has announced the acquisition of mcePharma. The acquisition and additional investments in the site of mcePharma will "strengthen" Brenntag’s capabilities across the pharma and biopharma value chain.
Medicines Discovery Catapult (MDC) and the Francis Crick Institute have announced a new strategic partnership to support the delivery of KQ Labs, a national accelerator for data-driven health science start-ups.
European Pharmaceutical Manufacturer asks John McDermott, vice president of scientific consulting at Quotient Sciences what the benefits are of using a CRDMO?
OneChain Immunotherapeutics (OCI), a clinical-stage biotech company focused on the development of CAR-T therapies for the treatment of oncologic diseases, has announced the appointment of Barbara Krebs-Pohl as the new chair of the Board of Directors.
Enterome SA presented new positive data from its ongoing Phase 1/2 “AUDREY” trial of its OncoMimics immunotherapy, EO4010, at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.
Europe’s rollout of ISO IDMP product data standards is well underway now, and EMA’s aligned Product Management Services (PMS) platform, now live, is the next priority - with deadlines for enriching existing data hitting from the end of this year.
iOnctura, a clinical-stage biopharmaceutical company, has announced the appointments of Steven Sciuto as chief financial officer (CFO) and Michelle Tsai PharmD as chief operating officer (COO).
